Published in Curr Med Res Opin on April 01, 2006
The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate. Br J Pharmacol (2008) 1.00
A green and black tea extract benefits urological health in men with lower urinary tract symptoms. Ther Adv Urol (2014) 0.75
Bawu Decoction () ameliorates benign prostatic hyperplasia in rats. Chin J Integr Med (2016) 0.75
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy. Kidney Int (2008) 2.46
Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov (2006) 2.23
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.70
Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol (2009) 1.67
Once-daily evening administration of mometasone furoate in asthma treatment initiation. Ann Allergy Asthma Immunol (2006) 1.53
A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol (2010) 1.39
Long-term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5alpha-reductase inhibitor dutasteride: results of 4-year studies. BJU Int (2005) 1.18
Modular psychotherapy for anxiety in older primary care patients. Am J Geriatr Psychiatry (2009) 1.16
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15
Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit (2004) 1.05
Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin (2009) 0.97
Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema. J Allergy Clin Immunol (2007) 0.95
Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens (2004) 0.94
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting. Am Heart J (2006) 0.90
Screening for generalized anxiety disorder in geriatric primary care patients. Int J Geriatr Psychiatry (2007) 0.85
Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial. Blood Press Monit (2005) 0.85
Telmisartan effects on insulin resistance in obese or overweight adults without diabetes or hypertension. J Clin Hypertens (Greenwich) (2010) 0.84
Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension. J Clin Hypertens (Greenwich) (2006) 0.84
Medical conditions and depressive, anxiety, and somatic symptoms in older adults with and without generalized anxiety disorder. Aging Ment Health (2010) 0.82
Migraine frequency and health utilities: findings from a multisite survey. Value Health (2008) 0.82
Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial. Am J Hypertens (2003) 0.82
The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials. Blood Press Monit (2007) 0.81
Valdecoxib for treatment of a single, acute, moderate to severe migraine headache. Headache (2005) 0.80
Predictors of response to tiotropium versus salmeterol in asthmatic adults. J Allergy Clin Immunol (2013) 0.80
Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients. J Clin Hypertens (Greenwich) (2005) 0.80
Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial. Blood Press Monit (2008) 0.80
Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD. Respir Med (2013) 0.80
Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension. Clin Pediatr (Phila) (2010) 0.79
Dutasteride improves objective and subjective disease measures in men with benign prostatic hyperplasia and modest or severe prostate enlargement. J Urol (2006) 0.78
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study. Headache (2011) 0.78
Combination therapy in acute migraine treatment: the rationale behind the current treatment options. Postgrad Med (2006) 0.77
Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction. Ann Am Thorac Soc (2014) 0.77
Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache. Curr Med Res Opin (2006) 0.76
Anticholinergics/antimuscarinic drugs in asthma. Curr Allergy Asthma Rep (2014) 0.76
The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. Am J Sports Med (2006) 0.76
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements. J Clin Hypertens (Greenwich) (2006) 0.75
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker. J Clin Hypertens (Greenwich) (2003) 0.75